Home LiteratureArticle Details
PMID: 8133465 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Comparison of four basic models of indirect pharmacodynamic responses.

Journal of pharmacokinetics and biopharmaceutics ·Vol. 21 ·No. 4 ·1993-08-00 ·Pages 457-78

Dayneka NL, Garg V, Jusko WJ

Abstract

Four basic models for characterizing indirect pharmacodynamic responses after drug administration have been developed and compared. The models are based on drug effects (inhibition or stimulation) on the factors controlling either the input or the dissipation of drug response. Pharmacokinetic parameters of methylprednisolone were used to generate plasma concentration and response-time profiles using computer simulations. It was found that the responses produced showed a slow onset and a slow return to baseline. The time of maximal response was dependent on the model and dose. In each case, hysteresis plots showed that drug concentrations preceded the response. When the responses were fitted with pharmacodynamic models based on distribution to a hypothetical effect compartment, the resulting parameters were dose-dependent and inferred biological implausibility. Indirect response models must be treated as distinct from conventional pharmacodynamic models which assume direct action of drugs. The assumptions, equations, and data patterns for the four basic indirect response models provide a starting point for evaluation of pharmacologic effects where the site of action precedes or follows the measured response variable.

MeSH Terms
Humans Infusions, Intravenous Methylprednisolone/blood,pharmacokinetics,pharmacology Models, Theoretical
Chemicals
Methylprednisolone
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Dayneka N L
Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo 14260.
Garg V
Jusko W J
References (21)
21 references, click to expand
  1. Pharmacokinetic and pharmacodynamic modeling in vivo.
    Crit Rev Bioeng. 1981;5(4):273-322 PMID: 7023829
  2. Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203-922.
    J Pharmacokinet Biopharm. 1991 Jun;19(3):287-309 PMID: 1875283
  3. Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin.
    Clin Pharmacol Ther. 1969 Jan-Feb;10(1):22-35 PMID: 5765183
  4. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.
    Clin Pharmacol Ther. 1979 Mar;25(3):358-71 PMID: 761446
  5. Diuretic effect and diuretic efficiency after intravenous dosage of frusemide.
    Br J Clin Pharmacol. 1990 Feb;29(2):215-9 PMID: 2306413
  6. Remoxipride: pharmacokinetics and effect on plasma prolactin.
    Br J Clin Pharmacol. 1991 Sep;32(3):355-60 PMID: 1685665
  7. Receptor-mediated pharmacodynamics of prednisolone in the rat.
    J Pharmacokinet Biopharm. 1986 Oct;14(5):469-93 PMID: 2879901
  8. Pharmacodynamics of methylprednisolone phosphate after single intravenous administration to healthy volunteers.
    Pharm Res. 1991 Feb;8(2):263-8 PMID: 2023879
  9. Semiparametric approach to pharmacokinetic-pharmacodynamic data.
    Am J Physiol. 1989 Apr;256(4 Pt 2):R1005-10 PMID: 2705568
  10. Dynamics of tolbutamide, glucose, and insulin interrelationships following varying doses of intravenous tolbutamide in normal subjects.
    Diabetes. 1975 Apr;24(4):354-67 PMID: 1132601
  11. Pharmacokinetic-pharmacodynamic modeling of prednisolone-induced lymphocytopenia in man.
    J Pharmacol Exp Ther. 1984 May;229(2):539-46 PMID: 6716275
  12. Pharmacoimmunodynamics of methylprednisolone: trafficking of helper T lymphocytes.
    J Pharmacokinet Biopharm. 1992 Aug;20(4):319-31 PMID: 1479558
  13. Modeling the pharmacokinetics and pharmacodynamics of dexamethasone in depressed patients.
    Eur J Clin Pharmacol. 1992;43(1):51-5 PMID: 1505609
  14. Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics.
    Clin Pharmacokinet. 1988 Nov;15(5):295-318 PMID: 2849518
  15. Pharmacodynamic modeling of prednisolone effects on natural killer cell trafficking.
    Pharm Res. 1995 Mar;12(3):459-63 PMID: 7617538
  16. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Clin Pharmacokinet. 1991 Mar;20(3):218-36 PMID: 1673880
  17. Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics.
    J Pharmacokinet Biopharm. 1991 Oct;19(5):521-36 PMID: 1783990
  18. Red blood cell sorbitol lowering effects and tolerance of single doses of AL 1576 (HOE 843) in diabetic patients.
    J Clin Pharmacol. 1988 Aug;28(8):757-61 PMID: 3145943
  19. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.
    Clin Pharmacokinet. 1981 Nov-Dec;6(6):429-53 PMID: 7032803
  20. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects.
    Clin Pharmacol Ther. 1989 Dec;46(6):616-28 PMID: 2689044
  21. Corticosteroid pharmacodynamic modeling: osteocalcin suppression by prednisolone.
    Pharm Res. 1992 Aug;9(8):1096-8 PMID: 1409384
Article Info
Journal
Journal of pharmacokinetics and biopharmaceutics
Abbr.
J Pharmacokinet Biopharm
ISSN
0090-466X
Published
1993-08-00
Pages
457-78
Language
English
Region
United States
NLM ID
0357115
PMCID
PMC4207304
Subset
IM
Grants
NIGMS NIH HHS · R37 GM024211 · United States
PHS HHS · 24211 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com